Treatment of Central Retinal Artery Occlusion with Hyperbaric Oxygen Therapy

Central Retinal Artery Occlusion (CRAO) is a medical emergency that can result in sudden, severe vision loss. This condition occurs when the blood flow to the retina is blocked, typically by a clot or embolism, depriving the retinal tissue of oxygen. Without immediate intervention, the lack of oxygen can cause irreversible damage to the retina, leading to permanent vision impairment or blindness. Early treatment is critical to minimize tissue damage and maximize the chances of recovery.

Hyperbaric Oxygen Therapy (HBOT) offers a promising adjunctive treatment option for CRAO. By delivering pure oxygen in a pressurized chamber, HBOT allows significantly higher levels of oxygen to dissolve into the bloodstream, reaching the retina and other oxygen-deprived tissues. This increased oxygenation can help preserve retinal tissue by supporting cellular metabolism, reducing inflammation, and preventing further damage during the critical period after the occlusion. HBOT also improves oxygen delivery to the ischemic retina, helping to keep cells viable while the body works to restore normal blood flow.

At Hyperbaric Health Services, we provide personalized HBOT treatments in a safe, clinical environment, ensuring our patients receive the highest quality of care. For individuals facing CRAO, HBOT can be a critical part of a comprehensive treatment plan, helping to protect vision and improve recovery outcomes. With our expert team and advanced technology, we are committed to providing effective solutions for those affected by this serious condition.